5 Einträge gefunden

1. High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer

   1. Lebok, Patrick
   2. Öztürk, Eray
   3. Heilenkötter, Uwe
   4. Jaenicke, Fritz
   5. Müller, Volkmar
   6. Paluchowski, Peter
   7. Geist, Stefan

   2016 - Forschungsinformationssystem des UKE
2. Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer: a TMA-based immunohistochemical study on 2,197 breast cancer patients

   1. Burandt, Eike
   2. Bari Noubar, Tanaz
   3. Lebeau, Annette
   4. Minner, Sarah
   5. Burdelski, Christoph
   6. Jänicke, Fritz
   7. Müller, Volkmar

   2014 - Forschungsinformationssystem des UKE
3. Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.

   1. Burandt, Eike Christian
   2. Jens, G
   3. Holst, Frederik
   4. Jänicke, Fritz
   5. Müller, Volkmar
   6. Quaas, Alexander
   7. Choschzick, Matthias

   2013 - Forschungsinformationssystem des UKE
4. Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancer.

   1. Witzel, Isabell
   2. Thomssen, C
   3. Krenkel, S
   4. Wilczak, Waldemar
   5. Bubenheim, M
   6. Pantel, K
   7. Neumann, R

   2006 - Forschungsinformationssystem des UKE
5. Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.

   1. Müller, Volkmar
   2. Witzel, Isabell
   3. Lück, Hans Joachim
   4. Köhler, Günter
   5. von Minckwitz, Gunther
   6. Möbus, Volker
   7. Sattler, Daniel

   2004 - Forschungsinformationssystem des UKE